SpotSee Launches Temperature Monitor for Insulin and GLP-1 Medications

The single-use indicators have a color-changing mechanism.

Screenshot 2024 04 10 At 9 43 37 Am

SpotSee today announced the launch of TempMonitor, a single-use temperature indicator designed specifically for patients who rely on insulin and Glucagon-like, peptide-1 (GLP-1) medications. TempMonitor helps distributors and patients know that their refrigerated medications have remained within the manufacturers’ recommended temperature ranges. The product will be on display at LogiPharma 2024, April 16 to 18 at Centre de Congrès de Lyon in Lyon, France, booth #39.

TempMonitor uses SpotSee’s WarmMark technology to provide visual evidence if a medication is exposed to unacceptable temperature levels. These mini single-use indicators have a color-changing mechanism that alerts users when the temperature exceeds 30 degrees Celsius (86 degrees Fahrenheit), signaling possible compromise of product quality.

The window of the TempMonitor indicator will stay white as long as no evidence of temperature excursions exist. But if the temperature climbs beyond 30 degrees Celsius (86 degrees Fahrenheit) within 30 minutes, the indicator will show red – signaling that the product was exposed to higher than recommended conditions. In this way, patients know how long the product had been exposed above the threshold temperature.

More in Devices